BR0212975A - Elemento de liberação de dosagem controlada, e, métodos para a liberação de pelo menos um primeiro agente ativo para dentro do rúmen de um animal ruminante, para o tratamento, a profilaxia ou ambos de um estado infestado ou doentio em um animal ruminante e para a alteração do estado fisiológico de um animal ruminante - Google Patents
Elemento de liberação de dosagem controlada, e, métodos para a liberação de pelo menos um primeiro agente ativo para dentro do rúmen de um animal ruminante, para o tratamento, a profilaxia ou ambos de um estado infestado ou doentio em um animal ruminante e para a alteração do estado fisiológico de um animal ruminanteInfo
- Publication number
- BR0212975A BR0212975A BR0212975-2A BR0212975A BR0212975A BR 0212975 A BR0212975 A BR 0212975A BR 0212975 A BR0212975 A BR 0212975A BR 0212975 A BR0212975 A BR 0212975A
- Authority
- BR
- Brazil
- Prior art keywords
- ruminant animal
- active agent
- rumen
- animal
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0068—Rumen, e.g. rumen bolus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"ELEMENTO DE LIBERAçãO DE DOSAGEM CONTROLADA, E, MéTODOS PARA A LIBERAçãO DE PELO MENOS UM PRIMEIRO AGENTE ATIVO PARA DENTRO DO RúMEN DE UM ANIMAL RUMINANTE, PARA O TRATAMENTO, A PROFILAXIA OU AMBOS DE UM ESTADO INFESTADO OU DOENTIO EM UM ANIMAL RUMINANTE E PARA A ALTERAçãO DO ESTADO FISIOLóGICO DE UM ANIMAL RUMINANTE". A presente invenção refere-se a um elemento de liberação de dosagem controlada adaptado para ser inserido e retido dentro do rúmen de um animal ruminante. O elemento compreende: a) uma ou mais quantidades predeterminadas e distintas de pelo menos uma primeira formulação compreendendo pelo menos um primeiro agente ativo, a formulação estando adaptada para se dissolver nos fluidos do rúmen em uma velocidade tal que a dissolução de cada uma de uma ou mais quantidades de primeira formulação proporciona um episódio pulsado ou curto de liberação do primeiro agente ativo para dentro do rúmen; b) uma ou mais quantidades predeterminadas de pelo menos uma segunda formulação adaptada para se dissolver em uma velocidade controlada nos fluidos do rúmen; sendo que as uma ou mais quantidades de primeira formulação são proporcionadas em uma ou mais localizações predeterminadas dentro do elemento em relação às citadas uma ou mais quantidades de segunda formulação para uma ou mais liberações retardadas de pelo menos o primeiro agente ativo para dentro do rúmen em tempos predeterminados antes, durante, após, ou em qualquer combinação dos mesmos, de um período de tempo estendido predeterminado definido pela citada segunda formulação. A invenção também se refere a um método para a liberação de pelo menos um primeiro agente ativo no rúmen de um animal ruminante em uma maneira retardada em um ou mais tempos predeterminados após a administração ao animal de uma composição contendo o agente ativo, o método compreendendo a administração ao animal de um elemento de liberação de dosagem controlada de acordo com a invenção. O primeiro agente ativo tipicamente será para o tratamento, a profilaxia ou ambos de um estado infestado ou doentio em um animal ruminante, ou para a alteração do estado fisiológico de um animal ruminante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR8390A AUPR839001A0 (en) | 2001-10-19 | 2001-10-19 | Dosage form, device and methods of treatment |
PCT/AU2002/001426 WO2003033031A1 (en) | 2001-10-19 | 2002-10-18 | Dosage form, device and methods of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0212975A true BR0212975A (pt) | 2004-10-13 |
Family
ID=3832213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0212975-2A BR0212975A (pt) | 2001-10-19 | 2002-10-18 | Elemento de liberação de dosagem controlada, e, métodos para a liberação de pelo menos um primeiro agente ativo para dentro do rúmen de um animal ruminante, para o tratamento, a profilaxia ou ambos de um estado infestado ou doentio em um animal ruminante e para a alteração do estado fisiológico de um animal ruminante |
Country Status (22)
Country | Link |
---|---|
US (1) | US20050064032A1 (pt) |
EP (1) | EP1448151A4 (pt) |
JP (1) | JP2005510485A (pt) |
KR (1) | KR20050037410A (pt) |
CN (1) | CN1571663A (pt) |
AR (1) | AR037116A1 (pt) |
AU (5) | AUPR839001A0 (pt) |
BR (1) | BR0212975A (pt) |
CA (1) | CA2463674A1 (pt) |
CR (1) | CR7312A (pt) |
EA (1) | EA005778B1 (pt) |
EC (1) | ECSP045063A (pt) |
HR (1) | HRP20040231A2 (pt) |
HU (1) | HUP0401808A3 (pt) |
IL (1) | IL160754A0 (pt) |
MX (1) | MXPA04003679A (pt) |
NO (1) | NO20041941L (pt) |
NZ (1) | NZ531672A (pt) |
PE (1) | PE20030519A1 (pt) |
PL (1) | PL368387A1 (pt) |
WO (1) | WO2003033031A1 (pt) |
ZA (1) | ZA200403743B (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRN20030021A1 (it) | 2003-07-21 | 2005-01-22 | Ascor Chimici Srl | Composizione di materia comprendente particelle contenenti cloruro di colina da somministrare in forma ruminalmente protetta e post-ruminalmente efficace. |
ITMI20041820A1 (it) * | 2004-09-24 | 2004-12-24 | Ascor Chimici Srl | Composizione in micro-pellets a rilascio controllato di sostanze fisiologicamente attive, procedimento di preparazione e relativo impiego nel settore zootecnico. |
US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
US20060246003A1 (en) * | 2004-12-27 | 2006-11-02 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
JP2008525313A (ja) * | 2004-12-27 | 2008-07-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬の安定化方法 |
NZ554260A (en) * | 2007-09-30 | 2010-05-28 | Agres Ltd | Selenomethionine andor selenocysteine administration to non-human animals to increase selenium content in protein sources |
WO2010126857A1 (en) * | 2009-04-28 | 2010-11-04 | Wyeth Llc | Parasiticidal combinations of macrocyclic lactones and polyether antibiotics |
AU2014203209B2 (en) * | 2009-07-31 | 2015-11-26 | Boehringer Ingelheim Animal Health USA Inc. | Sustained release capsules |
EP2459116B1 (en) * | 2009-07-31 | 2019-10-09 | Boehringer Ingelheim Animal Health USA Inc. | Sustained release capsules |
WO2011075592A1 (en) * | 2009-12-17 | 2011-06-23 | Merial Limited | Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles |
FR2992219B1 (fr) * | 2012-06-22 | 2014-07-11 | Aditec Lab | Composition pour le traitement de l'hypocalcemie chez les ruminants |
PT3164117T (pt) | 2014-07-03 | 2023-12-12 | SpecGx LLC | Formulações de libertação imediata de dissuasão de abuso compreendendo polissacáridos não celulósicos |
JP2019504072A (ja) | 2016-02-08 | 2019-02-14 | スペックジーエックス エルエルシー | 徐放性及び濫用抑止特性を有するグルコマンナン含有医薬組成物 |
CN110035718B (zh) * | 2016-12-02 | 2021-04-06 | 克雷西奥生物科技有限公司 | 胃内滞留系统 |
WO2019005700A1 (en) * | 2017-06-26 | 2019-01-03 | Merial, Inc. | DOUBLE-ACTING PARASITICIDE GRANULATE COMPOSITIONS, METHODS AND USES THEREOF |
AU201811126S (en) * | 2017-08-25 | 2018-05-07 | Argenta Mfg Limited | Intraruminal device |
CN113329741A (zh) * | 2018-09-10 | 2021-08-31 | 阿根塔创新有限公司 | 递送装置中的缓释制剂 |
CA3112369A1 (en) * | 2018-09-10 | 2020-03-19 | Argenta Innovation Limited | Controlled release formulations in delivery devices |
EP3856160A4 (en) | 2018-09-25 | 2022-07-06 | SpecGx LLC | ANTI-ABUSE IMMEDIATE RELEASE CAPSULES DOSAGE FORMS |
MX2022001846A (es) * | 2019-08-14 | 2022-06-09 | Elanco Tiergesundheit Ag | Nuevo protector de alas para cápsula alada y método para usar el mismo. |
MX2022009689A (es) * | 2020-02-07 | 2022-11-08 | Elanco Animal Health Incorporated | Cápsula alada. |
AU2021278871A1 (en) * | 2020-05-28 | 2023-01-19 | Boehringer Ingelheim Animal Health USA Inc. | Bi-modal release intra-ruminal capsule device and methods of use thereof |
US11529310B2 (en) | 2020-12-08 | 2022-12-20 | Ruminant Biotech Corp Limited | Devices and methods for delivery of substances to animals |
CN113398337A (zh) * | 2021-06-23 | 2021-09-17 | 上海市肺科医院 | 包含抗结核药物缓释植入人工骨载体的脊柱内固定装置 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU520409B2 (en) * | 1977-05-25 | 1982-01-28 | Commonwealth Scientific And Industrial Research Organisation | Controlled release composition |
GB2077586A (en) * | 1980-06-12 | 1981-12-23 | Standard Telephones Cables Ltd | Sustained-release device |
NZ197543A (en) * | 1980-07-02 | 1984-12-14 | Commw Scient Ind Res Org | Controlled release compositions for inclusion in intraruminal devices |
US4416659A (en) * | 1981-11-09 | 1983-11-22 | Eli Lilly And Company | Sustained release capsule for ruminants |
NZ203203A (en) * | 1982-02-16 | 1985-09-13 | Commw Scient Ind Res Org | Controlled release device:gas diffusion limited |
IE54171B1 (en) * | 1982-06-22 | 1989-07-05 | Univ Glasgow | Device for introducing nutrients and/or therapeutic materials into ruminant animals |
GB8328916D0 (en) * | 1983-10-28 | 1983-11-30 | Castex Prod | Pharmaceutical pellet |
US4777049A (en) * | 1983-12-01 | 1988-10-11 | Alza Corporation | Constant release system with pulsed release |
GR851195B (pt) * | 1984-06-02 | 1985-11-25 | Castex Prod | |
US4723958A (en) * | 1986-05-23 | 1988-02-09 | Merck & Co., Inc. | Pulsatile drug delivery system |
US4867980A (en) * | 1986-10-10 | 1989-09-19 | Coopers Animal Health Australia Limited | Heavy density depot |
US4957494A (en) * | 1987-06-25 | 1990-09-18 | Alza Corporation | Multi-layer delivery system |
US5023088A (en) * | 1987-06-25 | 1991-06-11 | Alza Corporation | Multi-unit delivery system |
US4874388A (en) * | 1987-06-25 | 1989-10-17 | Alza Corporation | Multi-layer delivery system |
US5391381A (en) * | 1987-06-25 | 1995-02-21 | Alza Corporation | Dispenser capable of delivering plurality of drug units |
US5110597A (en) * | 1987-06-25 | 1992-05-05 | Alza Corporation | Multi-unit delivery system |
US5938654A (en) * | 1987-06-25 | 1999-08-17 | Alza Corporation | Osmotic device for delayed delivery of agent |
US4915949A (en) * | 1987-07-13 | 1990-04-10 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
GB8829089D0 (en) * | 1988-12-13 | 1989-01-25 | Coopers Animal Health | Intra ruminal device |
ES2044246T3 (es) * | 1989-02-11 | 1994-01-01 | Bayer Ag | Medicamentos con liberacion controlada del producto activo. |
US5110598A (en) * | 1989-06-30 | 1992-05-05 | Smithkline Beecham Corp. | Intermittent release dosage form |
US5126142A (en) * | 1989-07-18 | 1992-06-30 | Alza Corporation | Dispenser comprising ionophore |
US5017381A (en) * | 1990-05-02 | 1991-05-21 | Alza Corporation | Multi-unit pulsatile delivery system |
MX9200339A (es) * | 1991-01-28 | 1992-08-01 | Hoechst Ag | Preparado para la liberacion controlada de sustancias activas, que son apropiadas como terapeuticos o para mejorar el crecimiento y el aprovechamiento de los piensos en rumiantes |
US5417682A (en) * | 1991-01-30 | 1995-05-23 | Alza Corporation | Device for administering active agent to biological environment |
AU650113B2 (en) * | 1991-04-05 | 1994-06-09 | Eli Lilly And Company | Sustained release capsule and formulations |
US5240713A (en) * | 1991-09-27 | 1993-08-31 | Alza Corporation | Dual rate agent delivery device |
US5221278A (en) * | 1992-03-12 | 1993-06-22 | Alza Corporation | Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
BR9506533A (pt) * | 1994-01-20 | 1997-09-16 | Pastoral Agric Res Inst Nz Ltd | Dispositivo para administração de materiais benéficos a ruminantes |
AUPM897594A0 (en) * | 1994-10-25 | 1994-11-17 | Daratech Pty Ltd | Controlled release container |
CA2348871C (en) * | 1998-11-02 | 2009-04-14 | John G. Devane | Multiparticulate modified release composition |
US6569857B1 (en) * | 1999-05-03 | 2003-05-27 | Drugtech Corporation | Dietary supplement |
DE19956486A1 (de) * | 1999-11-24 | 2001-06-21 | Lohmann Therapie Syst Lts | Mehrschichtige Zubereitung zur gesteuerten, pulsartigen Abgabe von Wirkstoffen |
US7326425B2 (en) * | 1999-12-31 | 2008-02-05 | Rutgers, The State University | Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
WO2001064191A1 (de) * | 2000-02-28 | 2001-09-07 | Akzo Nobel N.V. | Körper für die kontrollierte abgabe von wirkstoffen |
-
2001
- 2001-10-19 AU AUPR8390A patent/AUPR839001A0/en not_active Abandoned
-
2002
- 2002-10-17 PE PE2002001028A patent/PE20030519A1/es not_active Application Discontinuation
- 2002-10-18 AU AU2002332975A patent/AU2002332975C1/en not_active Expired
- 2002-10-18 BR BR0212975-2A patent/BR0212975A/pt not_active IP Right Cessation
- 2002-10-18 IL IL16075402A patent/IL160754A0/xx unknown
- 2002-10-18 HU HU0401808A patent/HUP0401808A3/hu unknown
- 2002-10-18 AR ARP020103936A patent/AR037116A1/es unknown
- 2002-10-18 JP JP2003535833A patent/JP2005510485A/ja active Pending
- 2002-10-18 NZ NZ531672A patent/NZ531672A/en not_active IP Right Cessation
- 2002-10-18 MX MXPA04003679A patent/MXPA04003679A/es active IP Right Grant
- 2002-10-18 WO PCT/AU2002/001426 patent/WO2003033031A1/en active Application Filing
- 2002-10-18 EA EA200400557A patent/EA005778B1/ru not_active IP Right Cessation
- 2002-10-18 PL PL02368387A patent/PL368387A1/xx not_active Application Discontinuation
- 2002-10-18 KR KR1020047005590A patent/KR20050037410A/ko not_active Application Discontinuation
- 2002-10-18 CA CA002463674A patent/CA2463674A1/en not_active Abandoned
- 2002-10-18 EP EP02801251A patent/EP1448151A4/en not_active Withdrawn
- 2002-10-18 US US10/490,975 patent/US20050064032A1/en not_active Abandoned
- 2002-10-18 CN CNA028207009A patent/CN1571663A/zh active Pending
-
2004
- 2004-03-09 HR HR20040231A patent/HRP20040231A2/hr not_active Application Discontinuation
- 2004-04-15 EC EC2004005063A patent/ECSP045063A/es unknown
- 2004-04-16 CR CR7312A patent/CR7312A/es unknown
- 2004-05-10 NO NO20041941A patent/NO20041941L/no not_active Application Discontinuation
- 2004-05-14 ZA ZA200403743A patent/ZA200403743B/en unknown
- 2004-09-09 AU AU2004210542A patent/AU2004210542C1/en not_active Expired
-
2005
- 2005-10-28 AU AU2005227413A patent/AU2005227413A1/en not_active Abandoned
-
2009
- 2009-12-16 AU AU2009250987A patent/AU2009250987A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2004210542A1 (en) | 2004-09-30 |
HRP20040231A2 (en) | 2004-08-31 |
AU2002332975B9 (en) | 2005-03-17 |
CN1571663A (zh) | 2005-01-26 |
AU2004210542B9 (en) | 2005-09-01 |
WO2003033031A1 (en) | 2003-04-24 |
IL160754A0 (en) | 2004-08-31 |
AU2002332975C1 (en) | 2009-01-29 |
AU2004210542B2 (en) | 2005-07-28 |
PL368387A1 (en) | 2005-03-21 |
MXPA04003679A (es) | 2004-07-23 |
AU2005227413A1 (en) | 2005-11-17 |
AU2002332975B2 (en) | 2005-02-03 |
EP1448151A4 (en) | 2010-01-13 |
US20050064032A1 (en) | 2005-03-24 |
AUPR839001A0 (en) | 2001-11-15 |
EP1448151A1 (en) | 2004-08-25 |
JP2005510485A (ja) | 2005-04-21 |
AU2009250987A1 (en) | 2010-01-14 |
CA2463674A1 (en) | 2003-04-24 |
ECSP045063A (es) | 2004-05-28 |
HUP0401808A3 (en) | 2005-11-28 |
ZA200403743B (en) | 2005-05-16 |
CR7312A (es) | 2004-10-27 |
AR037116A1 (es) | 2004-10-20 |
NO20041941L (no) | 2004-05-10 |
KR20050037410A (ko) | 2005-04-21 |
HUP0401808A2 (hu) | 2005-01-28 |
EA200400557A1 (ru) | 2005-02-24 |
PE20030519A1 (es) | 2003-06-13 |
AU2004210542C1 (en) | 2009-01-08 |
EA005778B1 (ru) | 2005-06-30 |
NZ531672A (en) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0212975A (pt) | Elemento de liberação de dosagem controlada, e, métodos para a liberação de pelo menos um primeiro agente ativo para dentro do rúmen de um animal ruminante, para o tratamento, a profilaxia ou ambos de um estado infestado ou doentio em um animal ruminante e para a alteração do estado fisiológico de um animal ruminante | |
BRPI0409715A (pt) | pelìculas comestìveis de dissolução rápida contendo um edulcorante | |
ES2569949T3 (es) | Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina | |
AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
SE8602722D0 (sv) | Hallbara administreringsformer | |
BR0116945A (pt) | Uma preparação para prevenção de restenose | |
ES2155473T3 (es) | Composicion veterinaria que contiene un inhibidor de las bombas de protones. | |
DE69931159D1 (de) | Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat | |
AR033688A1 (es) | Composicion parenteral reconstituible | |
MX169322B (es) | Formulacion farmaceutica de liberacion prolongada | |
PA8601801A1 (es) | Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad | |
Leonards | Presence of acetylsalicylic acid in plasma following oral ingestion of aspirin | |
BR0314943A (pt) | Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes | |
ATE287710T1 (de) | Verfahren zum modulieren der mikrozirkulation | |
BR9912508A (pt) | Métodos e composições transdérmicas para alìvio da dor | |
BRPI0408655A (pt) | formulações compreendendo um agente ativo e cacau em pó e a sua utilização | |
AR027748A1 (es) | Pequenas esferas o globulos que contienen estavudina y permiten la liberacion controlada de la misma | |
WO2002034267A8 (de) | Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen | |
BR0014895A (pt) | Formulação lìquida estável, processo para a preparação da mesma, uso da mesma, uso de polietileno glicol e sal de sódio ou potássio de um inibidor h+, k+-atpase, e, método para tratar doenças gastrointestinais | |
BR0308229A (pt) | Medicamentos contendo ingredientes ativos que diminuem o nìvel de colesterol com liberação do ingrediente ativo de tempo tardio | |
CO5241355A1 (es) | Forma envasada de composiciones farmaceuticas nucleosidicas activas para vacunas contra la hepatitis | |
AR046410A1 (es) | Composiciones farmaceuticas para la liberacion modificada de modafinilo | |
NO912414D0 (no) | Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling. | |
BRPI0513806A (pt) | composição medicinal contendo remédio para diabetes | |
BRPI0410374A (pt) | composição farmacêutica que compreende valsartano |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012. |